Cargando…

Impact of an integrated care program on glycemic control and cardiovascular risk factors in patients with type 2 diabetes in Saudi Arabia: an interventional parallel-group controlled study

BACKGROUND: Long intervals between patient visits and limited time with patients can result in clinical inertia and suboptimal achievement of treatment goals. These obstacles can be improved with a multidisciplinary care program. The present study aimed to assess the impact of such a program on glyc...

Descripción completa

Detalles Bibliográficos
Autores principales: Tourkmani, Ayla M., Abdelhay, Osama, Alkhashan, Hesham I., Alaboud, Aboud F., Bakhit, Ahmed, Elsaid, Tarek, Alawad, Ahmed, Alobaikan, Aljohara, Alqahtani, Hala, Alqahtani, Abdulaziz, Mishriky, Adel, bin Rsheed, Abdulaziz, Alharbi, Turki J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748946/
https://www.ncbi.nlm.nih.gov/pubmed/29291706
http://dx.doi.org/10.1186/s12875-017-0677-2
_version_ 1783289496736890880
author Tourkmani, Ayla M.
Abdelhay, Osama
Alkhashan, Hesham I.
Alaboud, Aboud F.
Bakhit, Ahmed
Elsaid, Tarek
Alawad, Ahmed
Alobaikan, Aljohara
Alqahtani, Hala
Alqahtani, Abdulaziz
Mishriky, Adel
bin Rsheed, Abdulaziz
Alharbi, Turki J.
author_facet Tourkmani, Ayla M.
Abdelhay, Osama
Alkhashan, Hesham I.
Alaboud, Aboud F.
Bakhit, Ahmed
Elsaid, Tarek
Alawad, Ahmed
Alobaikan, Aljohara
Alqahtani, Hala
Alqahtani, Abdulaziz
Mishriky, Adel
bin Rsheed, Abdulaziz
Alharbi, Turki J.
author_sort Tourkmani, Ayla M.
collection PubMed
description BACKGROUND: Long intervals between patient visits and limited time with patients can result in clinical inertia and suboptimal achievement of treatment goals. These obstacles can be improved with a multidisciplinary care program. The present study aimed to assess the impact of such a program on glycemic control and cardiovascular risk factors. METHODS: In a randomized, parallel-group trial, we assigned 263 patients with poorly controlled type 2 diabetes mellitus (T2DM) to either a control group, standard care program, or a multidisciplinary care program involving a senior family physician, clinical pharmacy specialist, dietician, diabetic educator, health educator, and social worker. The participants were followed for a median of 10 months, between September 2013 and September 2014. Glycated hemoglobin (HbA1c), fasting blood glucose (FBG), lipid profiles, and blood pressure (BP) were measured. The assignment was blinded for the assessors of the study outcomes. The study registry number is. RESULTS: In the intervention group, there were statistically significant (p < 0.05) post-intervention (relative) reductions in the levels of HbA1c (−27.1%, 95% CI = −28.9%, −25.3%), FBG (−17.10%, 95% CI = −23.3%, −10.9%), total cholesterol (−9.93%, 95% CI = −12.7%, −7.9%), LDL cholesterol (−11.4%, 95% CI = −19.4%, −3.5%), systolic BP (−1.5%, 95% CI = −2.9%, −0.03%), and diastolic BP (−3.4%, 95% CI = −5.2%, −1.7%). There was a significant decrease in the number of patients with a HbA1c ≥10 (86 mmol/mol) from 167 patients at enrollment to 11 patients after intervention (p < 0.001). However, the intervention group experienced a statistically significant increase in body weight (3.7%, 95% CI = 2.9%, 4.5%). In the control group, no statistically significant changes were noticed in different outcomes with the exception of total cholesterol (−4.10%, p = 0.07). In the linear regression model, the intervention and the total number of clinic visits predicted HbA1c improvement. CONCLUSIONS: Implementation of a patient-specific integrated care program involving a multidisciplinary team approach, frequent clinic visits, and intensified insulin treatment was associated with marked improvement in glycemic control and cardiovascular risk factors of poorly controlled T2DM patients in a safe and reproducible manner. TRIAL REGISTRATION: ISRCTN Identifier: ISRCTN83437562 September 19, 2016 Retrospectively registered. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12875-017-0677-2) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5748946
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-57489462018-01-05 Impact of an integrated care program on glycemic control and cardiovascular risk factors in patients with type 2 diabetes in Saudi Arabia: an interventional parallel-group controlled study Tourkmani, Ayla M. Abdelhay, Osama Alkhashan, Hesham I. Alaboud, Aboud F. Bakhit, Ahmed Elsaid, Tarek Alawad, Ahmed Alobaikan, Aljohara Alqahtani, Hala Alqahtani, Abdulaziz Mishriky, Adel bin Rsheed, Abdulaziz Alharbi, Turki J. BMC Fam Pract Research Article BACKGROUND: Long intervals between patient visits and limited time with patients can result in clinical inertia and suboptimal achievement of treatment goals. These obstacles can be improved with a multidisciplinary care program. The present study aimed to assess the impact of such a program on glycemic control and cardiovascular risk factors. METHODS: In a randomized, parallel-group trial, we assigned 263 patients with poorly controlled type 2 diabetes mellitus (T2DM) to either a control group, standard care program, or a multidisciplinary care program involving a senior family physician, clinical pharmacy specialist, dietician, diabetic educator, health educator, and social worker. The participants were followed for a median of 10 months, between September 2013 and September 2014. Glycated hemoglobin (HbA1c), fasting blood glucose (FBG), lipid profiles, and blood pressure (BP) were measured. The assignment was blinded for the assessors of the study outcomes. The study registry number is. RESULTS: In the intervention group, there were statistically significant (p < 0.05) post-intervention (relative) reductions in the levels of HbA1c (−27.1%, 95% CI = −28.9%, −25.3%), FBG (−17.10%, 95% CI = −23.3%, −10.9%), total cholesterol (−9.93%, 95% CI = −12.7%, −7.9%), LDL cholesterol (−11.4%, 95% CI = −19.4%, −3.5%), systolic BP (−1.5%, 95% CI = −2.9%, −0.03%), and diastolic BP (−3.4%, 95% CI = −5.2%, −1.7%). There was a significant decrease in the number of patients with a HbA1c ≥10 (86 mmol/mol) from 167 patients at enrollment to 11 patients after intervention (p < 0.001). However, the intervention group experienced a statistically significant increase in body weight (3.7%, 95% CI = 2.9%, 4.5%). In the control group, no statistically significant changes were noticed in different outcomes with the exception of total cholesterol (−4.10%, p = 0.07). In the linear regression model, the intervention and the total number of clinic visits predicted HbA1c improvement. CONCLUSIONS: Implementation of a patient-specific integrated care program involving a multidisciplinary team approach, frequent clinic visits, and intensified insulin treatment was associated with marked improvement in glycemic control and cardiovascular risk factors of poorly controlled T2DM patients in a safe and reproducible manner. TRIAL REGISTRATION: ISRCTN Identifier: ISRCTN83437562 September 19, 2016 Retrospectively registered. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12875-017-0677-2) contains supplementary material, which is available to authorized users. BioMed Central 2018-01-02 /pmc/articles/PMC5748946/ /pubmed/29291706 http://dx.doi.org/10.1186/s12875-017-0677-2 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Tourkmani, Ayla M.
Abdelhay, Osama
Alkhashan, Hesham I.
Alaboud, Aboud F.
Bakhit, Ahmed
Elsaid, Tarek
Alawad, Ahmed
Alobaikan, Aljohara
Alqahtani, Hala
Alqahtani, Abdulaziz
Mishriky, Adel
bin Rsheed, Abdulaziz
Alharbi, Turki J.
Impact of an integrated care program on glycemic control and cardiovascular risk factors in patients with type 2 diabetes in Saudi Arabia: an interventional parallel-group controlled study
title Impact of an integrated care program on glycemic control and cardiovascular risk factors in patients with type 2 diabetes in Saudi Arabia: an interventional parallel-group controlled study
title_full Impact of an integrated care program on glycemic control and cardiovascular risk factors in patients with type 2 diabetes in Saudi Arabia: an interventional parallel-group controlled study
title_fullStr Impact of an integrated care program on glycemic control and cardiovascular risk factors in patients with type 2 diabetes in Saudi Arabia: an interventional parallel-group controlled study
title_full_unstemmed Impact of an integrated care program on glycemic control and cardiovascular risk factors in patients with type 2 diabetes in Saudi Arabia: an interventional parallel-group controlled study
title_short Impact of an integrated care program on glycemic control and cardiovascular risk factors in patients with type 2 diabetes in Saudi Arabia: an interventional parallel-group controlled study
title_sort impact of an integrated care program on glycemic control and cardiovascular risk factors in patients with type 2 diabetes in saudi arabia: an interventional parallel-group controlled study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748946/
https://www.ncbi.nlm.nih.gov/pubmed/29291706
http://dx.doi.org/10.1186/s12875-017-0677-2
work_keys_str_mv AT tourkmaniaylam impactofanintegratedcareprogramonglycemiccontrolandcardiovascularriskfactorsinpatientswithtype2diabetesinsaudiarabiaaninterventionalparallelgroupcontrolledstudy
AT abdelhayosama impactofanintegratedcareprogramonglycemiccontrolandcardiovascularriskfactorsinpatientswithtype2diabetesinsaudiarabiaaninterventionalparallelgroupcontrolledstudy
AT alkhashanheshami impactofanintegratedcareprogramonglycemiccontrolandcardiovascularriskfactorsinpatientswithtype2diabetesinsaudiarabiaaninterventionalparallelgroupcontrolledstudy
AT alaboudaboudf impactofanintegratedcareprogramonglycemiccontrolandcardiovascularriskfactorsinpatientswithtype2diabetesinsaudiarabiaaninterventionalparallelgroupcontrolledstudy
AT bakhitahmed impactofanintegratedcareprogramonglycemiccontrolandcardiovascularriskfactorsinpatientswithtype2diabetesinsaudiarabiaaninterventionalparallelgroupcontrolledstudy
AT elsaidtarek impactofanintegratedcareprogramonglycemiccontrolandcardiovascularriskfactorsinpatientswithtype2diabetesinsaudiarabiaaninterventionalparallelgroupcontrolledstudy
AT alawadahmed impactofanintegratedcareprogramonglycemiccontrolandcardiovascularriskfactorsinpatientswithtype2diabetesinsaudiarabiaaninterventionalparallelgroupcontrolledstudy
AT alobaikanaljohara impactofanintegratedcareprogramonglycemiccontrolandcardiovascularriskfactorsinpatientswithtype2diabetesinsaudiarabiaaninterventionalparallelgroupcontrolledstudy
AT alqahtanihala impactofanintegratedcareprogramonglycemiccontrolandcardiovascularriskfactorsinpatientswithtype2diabetesinsaudiarabiaaninterventionalparallelgroupcontrolledstudy
AT alqahtaniabdulaziz impactofanintegratedcareprogramonglycemiccontrolandcardiovascularriskfactorsinpatientswithtype2diabetesinsaudiarabiaaninterventionalparallelgroupcontrolledstudy
AT mishrikyadel impactofanintegratedcareprogramonglycemiccontrolandcardiovascularriskfactorsinpatientswithtype2diabetesinsaudiarabiaaninterventionalparallelgroupcontrolledstudy
AT binrsheedabdulaziz impactofanintegratedcareprogramonglycemiccontrolandcardiovascularriskfactorsinpatientswithtype2diabetesinsaudiarabiaaninterventionalparallelgroupcontrolledstudy
AT alharbiturkij impactofanintegratedcareprogramonglycemiccontrolandcardiovascularriskfactorsinpatientswithtype2diabetesinsaudiarabiaaninterventionalparallelgroupcontrolledstudy